These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The conservative management of chronic renal failure. Mathew TH Med J Aust; 1976 Apr; 1(14):483-6. PubMed ID: 933926 [TBL] [Abstract][Full Text] [Related]
46. Renin-angiotensin-aldosterone system in patients on maintenance hemodialysis. Ivić M; Strahinjić S; Stefanović V Acta Med Iugosl; 1987; 41(3):205-13. PubMed ID: 3661237 [No Abstract] [Full Text] [Related]
47. Dialysis disequilibrium syndrome: a critical care nursing challenge. Norris MK Dimens Crit Care Nurs; 1982; 1(1):17-21, 63. PubMed ID: 6922768 [No Abstract] [Full Text] [Related]
49. Patients with renal disease: fluids in balance. Winder E Nursing (Lond); 1980 May; (13):570-3. PubMed ID: 6900212 [No Abstract] [Full Text] [Related]
50. [Hypertonicity of the dialysis fluid on the neural motor conduction in patients in chronic hemodialysis. Short term study]. Treviño Becerra A; Sánchez Alonso J; Cueto Pérez JP; Kirrev M Prensa Med Mex; 1975; 40(5-6):145-53. PubMed ID: 1178638 [No Abstract] [Full Text] [Related]
51. [Bio-impedancemetry in the assessment of aqueous sectors of the body]. Ivanov GG; Meshcheriakov GN; Kravchenko NR; Zaks IO; Moroz VV; Nikolaev DV; Arapova OA Anesteziol Reanimatol; 1999; (1):59-63. PubMed ID: 10199052 [No Abstract] [Full Text] [Related]
52. Pathophysiology and management of fluid and electrolyte disturbances in patients on chronic dialysis with severe hyperglycemia. Tzamaloukas AH; Ing TS; Siamopoulos KC; Raj DS; Elisaf MS; Rohrscheib M; Murata GH Semin Dial; 2008; 21(5):431-9. PubMed ID: 18945331 [TBL] [Abstract][Full Text] [Related]
53. [Dialytic ascites: pathogenetic aspects and the possibilities of its treatment]. Ermolenko VM; Klepikov PV Ter Arkh; 1988; 60(6):48-51. PubMed ID: 3206369 [No Abstract] [Full Text] [Related]
54. [Effect of hemodialysis on the state of water metabolism in patients with renal insufficiency]. Vinogradova IL; Shakhsuvarov VD; Bagriantseva SIu; Riapolova IV; Shlimak VM Urol Nefrol (Mosk); 1985; (1):38-41. PubMed ID: 3976103 [No Abstract] [Full Text] [Related]
56. [Effect of tap water on the level of plasma magnesium in patients with terminal stage of chronic renal insufficiency treated by hemodialysis]. Bazhanova IM; Levitskiĭ ER Urol Nefrol (Mosk); 1975; (1):35-8. PubMed ID: 1118971 [No Abstract] [Full Text] [Related]
57. Is it time for spironolactone therapy in dialysis patients? Covic A; Gusbeth-Tatomir P; Goldsmith DJ Nephrol Dial Transplant; 2006 Apr; 21(4):854-8. PubMed ID: 16449287 [No Abstract] [Full Text] [Related]
58. [On some problems of dialysis in patients with kidney insufficiency]. Grál T; Sokol A; Rubini ME Vnitr Lek; 1968 Apr; 14(4):380-90. PubMed ID: 5662879 [No Abstract] [Full Text] [Related]
59. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression. Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134 [TBL] [Abstract][Full Text] [Related]
60. [The regulation of plasma aldosterone in hemodialysis patients]. Louis F; Zwahlen A; Favre H; Vallotton M Schweiz Med Wochenschr; 1980 Dec; 110(49):1882-4. PubMed ID: 7006078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]